UPDATE: Goldman Sachs Starts Oak Street Health (OSH) at Buy

(Updated - August 31, 2020 5:35 AM EDT)

(updating comment)

Goldman Sachs analyst Robert Jones initiates coverage on Oak Street Health (NYSE: OSH) with a Buy rating and a price target of $66.00.

The analyst comments "In our view, OSH represents an opportunity to buy into a unique capitated
MCO-agnostic provider model in the attractive MA end-market with growth opportunities in new and existing markets across the country."

For an analyst ratings summary and ratings history on Oak Street Health click here. For more ratings news on Oak Street Health click here.

Shares of Oak Street Health closed at $45.41 yesterday.

You May Also Be Interested In

• Jefferies Upgrades Husqvarna AB (HUSQB:SS) to Buy
• Veritex Holdings (VBTX) PT Raised to $26 at Piper Sandler
• Keefe, Bruyette & Woods Upgrades Trustmark (TRMK) to Outperform